Robert J. Schott Sangamo Therapeutics, Inc (SGMO) insider trading activity

SGMO Quotes by TradingView

Robert J. Schott is SVP, Head of Development of SANGAMO THERAPEUTICS, INC. Currently has a direct ownership of 75,537 shares of SGMO, which is worth approximately $77,047. The most recent transaction as insider was on Feb 25, 2022, when has been sold 41,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 75.5K
0% 3M change
0% 12M change
Total Value Held $77,047

Robert J. Schott Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 25 2022
BUY
Grant, award, or other acquisition
-
41,000 Added 35.18%
75,537 Common Stock
Feb 12 2022
SELL
Payment of exercise price or tax liability
$31,467 $5.76 p/Share
5,463 Reduced 13.66%
34,537 Common Stock
Feb 12 2021
BUY
Grant, award, or other acquisition
-
40,000 Added 50.0%
40,000 Common Stock
RJS

Robert J. Schott

SVP, Head of Development
Brisbane, CA

Track Institutional and Insider Activities on SGMO

Follow SANGAMO THERAPEUTICS, INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SGMO shares.

Notify only if

Insider Trading

Get notified when an Sangamo Therapeutics, Inc insider buys or sells SGMO shares.

Notify only if

News

Receive news related to SANGAMO THERAPEUTICS, INC

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on SGMO